Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study
Open accessAbstract
BACKGROUND: Fetal structural anomalies, which are detected by ultrasonography, have a range of genetic causes, including chromosomal aneuploidy, copy number variations (CNVs; which are detectable by chromosomal microarrays), and pathogenic sequence variants in developmental genes. Testing for aneuploidy and CNVs is routine during the investigation of fetal structural anomalies, but there is little information on the clinical usefulness of genome-wide next-generation sequencing in the prenatal setting. We therefore aimed to evaluate the proportion of fetuses with structural abnormalities that had identifiable variants in genes associated with developmental disorders when assessed with whole-exome sequencing (WES). METHODS: In this prospective cohort study, two groups in Birmingham and London recruited patients from 34 fetal medicine units in England and Scotland. We used whole-exome sequencing (WES) to evaluate the presence of genetic variants in developmental disorder genes (diagnostic genetic variants) in a cohort of fetuses with structural anomalies and samples from their parents, after exclusion of aneuploidy and large CNVs. Women were eligible for inclusion if they were undergoing invasive testing for identified nuchal translucency or structural anomalies in their fetus, as detected by ultrasound after 11 weeks of gestation. The partners of these women also had to consent to participate. Sequencing results were interpreted with a targeted virtual gene panel for developmental disorders that comprised 1628 genes. Genetic results related to fetal structural anomaly phenotypes were then validated and reported postnatally. The primary endpoint, which was assessed in all fetuses, was the detection of diagnostic genetic variants considered to have caused the fetal developmental anomaly. FINDINGS: The cohort was recruited between Oct 22, 2014, and June 29, 2017, and clinical data were collected until March 31, 2018. After exclusion of fetuses with aneuploidy and CNVs, 610 fetuses with structural anomalies and 1202 matched parental samples (analysed as 596 fetus-parental trios, including two sets of twins, and 14 fetus-parent dyads) were analysed by WES. After bioinformatic filtering and prioritisation according to allele frequency and effect on protein and inheritance pattern, 321 genetic variants (representing 255 potential diagnoses) were selected as potentially pathogenic genetic variants (diagnostic genetic variants), and these variants were reviewed by a multidisciplinary clinical review panel. A diagnostic genetic variant was identified in 52 (8·5%; 95% CI 6·4-11·0) of 610 fetuses assessed and an additional 24 (3·9%) fetuses had a variant of uncertain significance that had potential clinical usefulness. Detection of diagnostic genetic variants enabled us to distinguish between syndromic and non-syndromic fetal anomalies (eg, congenital heart disease only vs a syndrome with congenital heart disease and learning disability). Diagnostic genetic variants were present in 22 (15·4%) of 143 fetuses with multisystem anomalies (ie, more than one fetal structural anomaly), nine (11·1%) of 81 fetuses with cardiac anomalies, and ten (15·4%) of 65 fetuses with skeletal anomalies; these phenotypes were most commonly associated with diagnostic variants. However, diagnostic genetic variants were least common in fetuses with isolated increased nuchal translucency (≥4·0 mm) in the first trimester (in three [3·2%] of 93 fetuses). INTERPRETATION: WES facilitates genetic diagnosis of fetal structural anomalies, which enables more accurate predictions of fetal prognosis and risk of recurrence in future pregnancies. However, the overall detection of diagnostic genetic variants in a prospectively ascertained cohort with a broad range of fetal structural anomalies is lower than that suggested by previous smaller-scale studies of fewer phenotypes. WES improved the identification of genetic disorders in fetuses with structural abnormalities; however, before clinical implementation, careful consideration should be given to case selection to maximise clinical usefulness. FUNDING: UK Department of Health and Social Care and The Wellcome Trust.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the PAGE study, 69% of fetal abnormalities with a genetically diagnosable cause died perinatally or neonatally.
“In the PAGE study data, 69% of fetal abnormalities with a genetically diagnosable cause died perinatally or neonatally.”
From Evidence for 28 genetic disorders discovered by combining healthcare and research data (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587 · see citing works
Chromosomal microarray versus karyotyping for prenatal diagnosis
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., Savage, M., Platt, L. D., Saltzman, D., Grobman, W. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203382 · Cited by 1,412 · see citing works
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., Ward, P., Braxton, A., Wang, M., Buhay, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.14601 · Cited by 1,360 · see citing works
Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome
Ng, S. B. H., Bigham, A. W., Buckingham, K. J., Hannibal, M., McMillin, M. J., Gildersleeve, H. I. S., Beck, A. E., Tabor, H. K., Cooper, G. M., Mefford, H. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.646 · Cited by 1,349 · see citing works
Wright, C. F., Fitzgerald, T. W., Jones, W. D., Clayton, S., McRae, J. F., van Kogelenberg, M., King, D. A., Ambridge, K., Barrett, D. M., Bayzetinova, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61705-0 · Cited by 728 · see citing works
Self-citationPromises, pitfalls and practicalities of prenatal whole exome sequencing
Best, S. K., Wou, K., Vora, N. L., den Veyver, I. B. V., Wapner, R. J., & Chitty, L. S. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5102 · Cited by 372 · see citing works
Self-citationWright, C. F., McRae, J. F., Clayton, S., Gallone, G., Aitken, S., Fitzgerald, T. W., Jones, P., Prigmore, E., Rajan, D., Lord, J., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.246 · Cited by 320 · see citing works
Self-citationPersson, M., Cnattingius, S., Villamor, E., Söderling, J. K., Pasternak, B., Stephansson, O., & Neovius, M. (2017) · BMJ · doi:10.1136/bmj.j2563 · Cited by 290 · see citing works
CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms
Panizzi, J. R., Becker-Heck, A., Castleman, V., Al-Mutairi, D. A., Liu, Y., Loges, N. T., Pathak, N. H., Austin-Tse, C. A., Sheridan, E. G., Schmidts, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2277 · Cited by 249 · see citing works
Hillman, S., Pretlove, S. J., Coomarasamy, A., McMullan, D. J., Davison, E. V., Maher, E. R., & Kilby, M. D. (2010) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.7754 · Cited by 236 · see citing works
Self-citationExome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities
Drury, S., Williams, H. J., Trump, N., et al. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4675 · Cited by 223 · see citing works
Regier, A., Farjoun, Y., Larson, D. E., Krasheninina, O. A., Kang, H. M., Howrigan, D. P., Chen, B.-J., Kher, M., Banks, E., Ames, D. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06159-4 · Cited by 220 · see citing works
Duncan, A. J., Bitner-Glindzicz, M. A. K., Meunier, B., Costello, H., Hargreaves, I. P., López, L. C., Hirano, M., Quinzii, C. M., Sadowski, M. I., Hardy, J., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.018 · Cited by 218 · see citing works
Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound
Carss, K., Hillman, S., Parthiban, V., McMullan, D. J., Maher, E. R., Kilby, M. D., & Hurles, M. E. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu038 · Cited by 199 · see citing works
Self-citationClinical Diagnosis by Whole-Genome Sequencing of a Prenatal Sample
Talkowski, M. E., Ordulu, Z., Pillalamarri, V., Benson, C. B., Blumenthal, I., Connolly, S. A., Hanscom, C., Hussain, N., Pereira, S., Picker, J. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208594 · Cited by 195 · see citing works
Mutations in the β-Tubulin Gene TUBB5 Cause Microcephaly with Structural Brain Abnormalities
Breuss, M. W., Heng, J. I., Poirier, K., Tian, G., Jaglin, X. H., Qu, Z., Braun, A. D., Gstrein, T., Ngo, L., Haas, M., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.11.017 · Cited by 195 · see citing works
Banka, S., Veeramachaneni, R., Reardon, W., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.220 · Cited by 183 · see citing works
Rare Variants in NR2F2 Cause Congenital Heart Defects in Humans
Turki, S. H. A., Manickaraj, A. K., Mercer, C. L., Gerety, S. S., Hitz, M., Lindsay, S., D’Alessandro, L. C. A., Swaminathan, G. J., Bentham, J., Arndt, A.-K., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.03.007 · Cited by 179 · see citing works
Self-citationThe International Society for Prenatal Diagnosis, & The Society for Maternal and Fetal Medicine (2018) · Prenatal Diagnosis · doi:10.1002/pd.5195 · Cited by 177 · see citing works
Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges
Vora, N. L., Powell, B. C., Brandt, A., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.33 · Cited by 175 · see citing works
Chandler, N. J., Best, S. K., Hayward, J. D., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.30 · Cited by 167 · see citing works
Self-citationYates, C., Monaghan, K. G., Copenheaver, D., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.31 · Cited by 165 · see citing works
MLL2 mutation spectrum in 45 patients with Kabuki syndrome
Paulussen, A. D. C., Stegmann, A. P. A., Blok, M. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21416 · Cited by 142 · see citing works
Clinical and genetic aspects of KBG syndrome
Low, K. J., Ashraf, T., Canham, N. L. E., Clayton‐Smith, J., Deshpande, C., Donaldson, A., Fisher, R., Flinter, F. A., Foulds, N. C., Fryer, A. E., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37842 · Cited by 132 · see citing works
Self-citationOpening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing
Horn, R., & Parker, M. J. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5114 · Cited by 110 · see citing works
Self-citationAlamillo, C. L., Powis, Z., Hagman, K. D. F., Shahmirzadi, L., Weltmer, E. C., Turocy, J. F., Lowe, T. W., Kobelka, C., Chen, E., Basel, D., et al. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4648 · Cited by 102 · see citing works
Kabuki syndrome: clinical and molecular diagnosis in the first year of life
Dentici, M. L., Pede, A. D., Lepri, F. R., Gnazzo, M., Lombardi, M. H., Auriti, C., Petrocchi, S., Pisaneschi, E., Bellacchio, E., Capolino, R., et al. (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-305858 · Cited by 99 · see citing works
Hirata, H., Nanda, I., van Riesen, A. K., McMichael, G., Hu, H., Hambrock, M., Papon, M.-A., Fischer, U., Marouillat, S., Ding, C., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.03.021 · Cited by 93 · see citing works
Jenkins, L., Deans, Z. C., Lewis, C., & Allen, S. K. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5197 · Cited by 92 · see citing works
Self-citationGoldenberg, A., Riccardi, F., Tessier, A., Pfundt, R., Busa, T., Cacciagli, P., Capri, Y., Coutton, C., Delahaye‐Duriez, A., Frébourg, T., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37878 · Cited by 90 · see citing works
Mutations in Either TUBB or MAPRE2 Cause Circumferential Skin Creases Kunze Type
Misra‐Isrie, M., Breuss, M. W., Tian, G., Hansen, A. H., Cristofoli, F., Morandell, J., Kupchinsky, Z. A., Sifrim, A., Rodriguez, C. M. R., Dapena, E. P., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.10.014 · Cited by 85 · see citing works
ARCN1 Mutations Cause a Recognizable Craniofacial Syndrome Due to COPI-Mediated Transport Defects
Izumi, K., Brett, M., Nishi, E., Drunat, S., Tan, E. S., Fujiki, K., Lebon, S., Cham, B., Masuda, K., Arakawa, M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.06.011 · Cited by 84 · see citing works
Genotype-phenotype correlations in MYCN-related Feingold syndrome
Marcelis, C., Hol, F. A., Graham, G. E., Rieu, P. N. M. A., Kellermayer, R., Meijer, R. P. P., Lugtenberg, D., Scheffer, H., van Bokhoven, H., Brunner, H. G., et al. (2008) · Human Mutation · doi:10.1002/humu.20750 · Cited by 79 · see citing works
Pángalos, C., Hagnefelt, B., Λιλάκος, Κ., & Konialis, C. P. (2016) · PeerJ · doi:10.7717/peerj.1955 · Cited by 74 · see citing works
Wade, E. M., Daniel, P. B., Jenkins, Z. A., McInerney-Leo, A. M., Leo, P., Morgan, T., Addor, M. C., Adès, L. C., Bertola, D. R., Bohring, A., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.024 · Cited by 72 · see citing works
Westerfield, L. E., Stover, S. R., Mathur, V. S., et al. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4674 · Cited by 53 · see citing works
Danhauser, K., Herebian, D. A., Haack, T. B., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.133 · Cited by 51 · see citing works
De novo frameshift mutation in COUP‐TFII (NR2F2) in human congenital diaphragmatic hernia
High, F. A., Bhayani, P., Wilson, J. M., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37830 · Cited by 51 · see citing works
Robson, S. C., Chitty, L. S., Stephen Morris, A., Verhoef, T. I., Ambler, G., Wellesley, D. G., Graham, R. H., Leader, C., Fisher, J., & Crolla, J. A. (2017) · Efficacy and Mechanism Evaluation · doi:10.3310/eme04010 · Cited by 46 · see citing works
Self-citationMutation analysis in patients with total sperm immotility
Pereira, R., Oliveira, J., Ferráz, L., et al. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0474-6 · Cited by 39 · see citing works
KBG syndrome: An Australian experience
Murray, N., Burgess, B., Hay, R., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38121 · Cited by 37 · see citing works
Weiss, K., Applegate, C. D., Wang, T., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37210 · Cited by 34 · see citing works
Hillman, S., Pretlove, S. J., Coomarasamy, A., et al. (2010) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2010.192310.1.1 · Cited by 32 · see citing works
Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotype
Wade, E. M., Jenkins, Z. A., Daniel, P. B., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38267 · Cited by 32 · see citing works
Wapner, R. J., Petrovski, S., Brennan, K., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.11.009 · Cited by 25 · see citing works
Casey, J. P., Goggin, P., McDaid, J. R., et al. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0192-z · Cited by 20 · see citing works
Ackerman, J. P., Smestad, J. A., Tester, D. J., Qureshi, M. Y., Crabb, B., Mendelsohn, N. J., & Ackerman, M. J. (2016) · Congenital Heart Disease · doi:10.1111/chd.12400 · Cited by 20 · see citing works
Kabuki syndrome as a cause of non‐immune fetal hydrops/ascites
Long, A., Sinkovskaya, E. S., Edmondson, A. C., Zackai, E. H., & Vergano, S. A. S. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37956 · Cited by 16 · see citing works
D’Andrea, G., Schiavulli, M., Dimatteo, C., et al. (2013) · Blood · doi:10.1182/blood-2013-09-528943 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Evidence for 28 genetic disorders discovered by combining healthcare and research data
Kaplanis, J., Samocha, K. E., Wiel, L., Zhang, Z., Arvai, K. J., Eberhardt, R. Y., Gallone, G., Lelieveld, S. H., Martin, H. C., McRae, J. F., et al. (2020) · Nature · doi:10.1038/s41586-020-2832-5 · Cited by 615 · see citing works
Self-citationKaplanis, J., Samocha, K. E., Wiel, L., Zhang, Z., Arvai, K. J., Eberhardt, R. Y., Gallone, G., Lelieveld, S. H., Martin, H. C., McRae, J. F., et al. (2019) · doi:10.1101/797787 · Cited by 36 · see citing works
Self-citation
- Authors
- Lord, J., McMullan, D. J., Eberhardt, R. Y., Rinck, G., Hamilton, S. J., Quinlan-Jones, E., Prigmore, E., Keelagher, R., Best, S. K., Carey, G. K., Mellis, R., Robart, S., Berry, I. R., Chandler, K. E., Cilliers, D., Cresswell, L., Edwards, S. L., Gardiner, C., Henderson, A., Holden, S. T., Homfray, T., Lester, T., Lewis, R. A., Newbury-Ecob, R., Prescott, K., Quarrell, O. W., Ramsden, S. C., Roberts, E., Tapon, D., Tooley, M. J., Vasudevan, P. C., Weber, A. P., Wellesley, D. G., Westwood, P., White, H., Parker, M., Williams, D., Jenkins, L., Scott, R. H., Kilby, M. D., Chitty, L. S., Hurles, M. E., Maher, E. R., Bateman, M., Berry, I. R., Best, S. K., Campbell, C., Campbell, J., Carey, G., Chandler, K. E., Chitty, L. S., Cilliers, D., Cohen, K., Collingwood, E., Constantinou, P., Cresswell, L., Delmege, C., Eberhardt, R. Y., Edwards, S. L., Ellis, R., Evans, J., Everett, T., Pinto, C. F., Forrester, N., Fowler, E., Gardiner, C., Hamilton, S., Healey, K., Henderson, A., Holden, S. T., Homfray, T., Hudson, R., Hurles, M. E., Jenkins, L., Keelagher, R., Kilby, M. D., Lester, T., Lewis, R., Lord, J., Maher, E. R., Marton, T., McMullan, D. J., Mehta, S., Mellis, R., Newbury-Ecob, R., Park, S.-M., Parker, M., Prescott, K., Prigmore, E., Quarrell, O. W., Quinlan-Jones, E., Ramsden, S. C., Rinck, G., Robart, S., Roberts, E., Rowland, J., Scott, R. H., Steer, J., Tapon, D., Taylor, E. J., Tooley, M. J., Vasudevan, P. C., Weber, A. P., Wellesley, D. G., Westwood, P., White, H., Williams, D., & Wilson, E.
- Affiliations
- Churchill Hospital (GB)
- North Bristol NHS Trust (GB)
- National Health Service (GB)
- Leicester Royal Infirmary (GB)
- University of Southampton (GB)
- Great Ormond Street Hospital (GB)
- Wellcome Centre for Ethics and Humanities (GB)
- University of Oxford (GB)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 393
- Issue
- 10173
- Pages
- 747-757
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC6386638
- OpenAlex
- W2910583407
- Cited by
- 711
- References
- 49
- Citations by year
- 2026: 52 · 2025: 91 · 2024: 104 · 2023: 108 · 2022: 113 · 2021: 100 · 2020: 94 · 2019: 40 · 2018: 2 · 2015: 1 · 2013: 2
- FWCI
- 90.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Lancet (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion, cc-by)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- UK Department of Health and Wellcome Trust (no. HICF-R7-396)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
- Keywords
- fetal structural anomalies, prenatal exome sequencing, prenatal genetic diagnosis, fetal medicine, nuchal translucency, prenatal ultrasound, diagnostic yield, developmental disorders, copy number variation
- MeSH terms
- Congenital Abnormalities, Abortion, Spontaneous, Abortion, Eugenic, Exome Sequencing, Female, Fetus, Humans, Infant, Newborn, Male, Parents, Pregnancy, Prospective Studies, Fetal Development, Nuchal Translucency Measurement, Stillbirth, Live Birth, DNA Copy Number Variations, Abnormal Karyotype, Perinatal Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
